Patent details

EP2714911 Title: IMMUNOGENIC COMPOSITION

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2714911
WO Application Number:
EP2012059805
Type:
European Patent Granted for NL
Status:
Revoked
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP12726374.7
WO Publication Number:
WO2012163817
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Belgium (BE)
Publications:

Dates

Filing date:
25/05/2012
Grant date:
30/11/2016
EP Publication Date:
09/04/2014
WO Publication Date:
06/12/2012
Claims Translations Received Date:
Claims Translation B1 Received Date:
17/01/2017
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
30/11/2016
EP B1 Publication Date:
30/11/2016
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
24/05/2032
Lapsed By Expiration Date:
Revocation Date:
24/10/2023
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
30/11/2016
 
 

 

Name:
GlaxoSmithKline Biologicals S.A.
Address:
rue de l'Institut, 89, 1330 RIXENSART, Belgium (BE)

Domicile Holder

Name:
ir. F.A. Geurts c.s.
From:
17/01/2017
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

Name:
CASTADO, Cindy
Address:
B-1330 Rixensart, Belgium (BE)

Priority

1

Priority Patent Number:
201161490716 P
Priority Date:
27/05/2011
Priority Country:
United States of America (US)

2

Priority Patent Number:
201161490734 P
Priority Date:
27/05/2011
Priority Country:
United States of America (US)

3

Priority Patent Number:
201161490707 P
Priority Date:
27/05/2011
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 39/08; C07K 14/33; C12N 15/62;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
48/23
Publication date:
29/11/2023
Description:
Lapse or annulment

2

Bulletin Heading:
VB1
Journal edition number:
40/17
Publication date:
04/10/2017
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

3

Bulletin Heading:
EP3
Journal edition number:
04/17
Publication date:
25/01/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
48/16
Publication date:
30/11/2016
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202348
Publication date:
29/11/2023
Description:
Revocation of the European patent

2

Issue number:
201740
Publication date:
04/10/2017
Description:
Opposition procedure started

3

Issue number:
201648
Publication date:
30/11/2016
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
19/04/2023
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
600 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
24/01/2017 Outgoing Correspondence Letter no formal defects 1 PDF /2/1/2/1/1/0800111212/docs/ep12726374.7_1_112661l271.pdf
17/01/2017 Claims First filed claims 5 PDF /2/1/2/1/1/0800111212/docs/ep12726374.7_0_claims20170117120958123.pdf
17/01/2017 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /2/1/2/1/1/0800111212/docs/ep12726374.7_2_incomingcorrespondenceelectronic20170117121000943.pdf